June 8, 2017 / 11:24 AM / 6 months ago

BRIEF-Valeant announces sale of Inova Pharmaceuticals for $930 mln

June 8 (Reuters) - Valeant Pharmaceuticals International Inc

* Valeant announces sale of Inova Pharmaceuticals for $930 million

* Valeant - deal for $930 million in cash.

* Valeant - ‍will use proceeds from sale to permanently repay term loan debt under its senior secured credit facility​

* Valeant - ‍valeant will use proceeds from sale to permanently repay term loan debt under its senior secured credit facility​

* Valeant says transaction is expected to close in second half of 2017

* Valeant - agreement to sell inova pharmaceuticals business to company owned by funds advised and managed by pacific equity partners and carlyle group Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below